The global HIV research community has spent a ton of time, effort, and cash over the years to address a central concern: To what extent does a person's HIV status affect their long-term risk for heart disease, and how do other factors come into play? We've already seen the results of several major studies on this topic -- and this week, our lead story is about a massive meta-analysis that pulls them together.
But that's just one of the intriguing explorations of recently published research we've got on tap this week. Our four picks cover:
- Myocardial infarction risk among people with HIV.
- Dolutegravir vs. efavirenz : Brazil edition.
- A new tool to estimate the time interval in which a person acquired HIV.
- An "HIV Index" that may help identify people at imminent risk for disengagement from care.
Let's take a closer look at this new research. To beat HIV, you have to follow the science!